Nowadays, a variety of methods are employed to identify cancer-associated mutations in BRCA1. This study is aimed to assess the functional effects of two mutations, Asp1733Gly and Val1714Gly, using a combination of insilico tools and yeast functional transcription activator assay. Here, BRCA1 is linked to cancer.